²é¿´: 1509  |  »Ø¸´: 3
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

yangxicshe

Ìú³æ (СÓÐÃûÆø)

[½»Á÷] ¡¾ÇóÖú¡¿ÈܼÁ·åºÍÒ©·å×ÜÊÇÖØµþÔÚÒ»ÆðÁË£¬Ó¦¸ÃÔõôµ÷Õû±ÈÀý£¿ ÒÑÓÐ3È˲ÎÓë

Á÷¶¯ÏàµÄ×î¼Ñ±ÈÀý
¸÷λ×ÊÉîÈËÊ¿£¬ÎÒÊÇHPLCµÄÐÂÊÖ£¬ÏÖÔÚÔÚ×ö¶àÎ÷»·ËصÄHPLCµÄ²â¶¨£¬ÔÚ365nmµÄ²¨³¤Ï£¬Á÷¶¯ÏàÊÇ0.01M²ÝËá-ÒÒëæ-¼×´¼£¬Ô­À´µÄ±ÈÀýÊÇ

50:35:15£¬µ«ÊÇÈܼÁ·åºÍÒ©·å×ÜÊÇÖØµþÔÚÒ»ÆðÁË£¬Ó¦¸ÃÔõôµ÷Õû±ÈÀý°¡£¿¼×´¼£¬ÒÒëæµÄÎüÊÕ²¨³¤ÓÖÊǶàÉÙÄØ£¿ÆÚÅλظ´£¡
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xiaodu2007693

ľ³æ (ÖøÃûдÊÖ)

ҩѧ°æ~Áúè

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
ÈܼÁ·åÒ»°ã±È½Ï¿¿Ç°£¬Äã¿ÉÒÔ½µµÍÁ÷¶¯Ïà±ÈÀý£¬ÈÃÒ©ÎïÍùºóÍÏÒ»ÍÏ
»¶Ó­ÄúÀ´Ò©Ñ§°æ~
4Â¥2011-03-11 19:17:08
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 4 ¸ö»Ø´ð

dingjinglvde

ľ³æ (ÕýʽдÊÖ)

¡ï ¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
karl2100(½ð±Ò+1): ¶àлÌṩ£¡ 2011-03-11 19:48:21
ÈܼÁÈç¹ûÊÇÁ÷¶¯Ï࣬ÔÚ365nmÓ¦¸ÃûÓÐÎüÊÕ°¡
Èç¹ûÓз壬Ӧ¸ÃºÜС£¬³ö·åʱ¼äÒ²Ó¦¸ÃºÜÔçµÄ

USP33
ASSAY
•  Procedure
Mobile phase:  Transfer 2.72 g of monobasic potassium phosphate, 0.74 g of sodium hydroxide, 0.50 g of tetrabutylammonium hydrogen sulfate, and 0.40 g of edetate disodium to a 1000-mL volumetric flask. Add 850 mL of water, and stir to dissolve. Add 60 g of tertiary butyl alcohol with the aid of water, dilute with water to volume, and adjust with 1 N sodium hydroxide to a pH of 8.0 ¡À 0.1. Pass this solution through a filter having a porosity of 0.5 µm or finer, and degas before using. Decreasing the proportion of tertiary butyl alcohol results in a longer retention time of doxycycline and improved separation of doxycycline from the related compounds.
Diluent:  0.01 N hydrochloric acid
System suitability solution:  Prepare a solution of USP Doxycycline Hyclate RS in Diluent containing about 6 mg of doxycycline/mL. Transfer 5 mL of this solution to a 25-mL volumetric flask, heat on a steam bath for 60 min, and evaporate to dryness on a hot plate, taking care not to char the residue. Dissolve the residue in 0.01 N hydrochloric acid, dilute with Diluent to volume, and mix. Pass a portion of this solution through a filter having a porosity of 0.5 µm or finer, and use the filtrate. This solution contains a mixture of 4-epidoxycycline, 6-epidoxycycline, and doxycycline. When stored in a refrigerator, this solution may be used for 14 days.
[Note¡ªThroughout the following procedures, protect the Standard solution and the Sample solution from light. ]
Standard solution:  Transfer 12 mg of USP Doxycycline Hyclate RS, to a 10-mL volumetric flask, add 6 mL of Diluent, sonicate for about 5 min or until dissolved, and dilute with Diluent to volume.
Sample solution:  55 mg of Doxycycline in a 50-mL volumetric flask. Add 12 mL of 0.1 N hydrochloric acid, swirl to dissolve, and dilute with Diluent to volume. Filter through a filter of 0.5 µm or finer porosity.
Chromatographic system  
(See Chromatography 621, System Suitability.)
Mode:  LC
Detector:  UV 270 nm
Column:  4.6-mm ¡Á 25-cm; packing L21
Column temperature:  60 ¡À 1
Flow rate:  1 mL/min
Injection size:  20 µL
System suitability  
Sample:  System suitability solution and Standard solution
[Note¡ªThe relative retention times for 4-epidoxycycline (the main degradation product), 6-epidoxycycline, and doxycycline are 0.4, 0.7, and 1.0, respectively. ]
Suitability requirements  
Resolution:  NLT 3.0 between the 4-epidoxycycline peak and the doxycycline peak, System suitability solution
Tailing factor:  NMT 2.0, System suitability solution
Relative standard deviation:  NMT 2.0%, Standard solution
Analysis  
Samples:  Standard solution and Sample solution
Calculate the quantity of C22H24N2O8, in µg, in each mg of the Doxycycline taken:
Result = (rU/rS) ¡Á (CS/CU) ¡Á P
rU = = peak response from the Sample solution
rS = = peak response from the Standard solution
CS = = concentration of USP Doxycycline Hyclate RS in the Standard solution (mg/mL)
CU = = concentration of the Sample solution (mg/mL)
P = = designated potency of doxycycline (C22H24N2O8), of USP Doxycycline Hyclate RS (µg/mg)

Acceptance criteria:  NLT 880 µg/mg and NMT 980 µg/mg
2Â¥2011-03-11 17:18:54
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

cjl2fl

½ð³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
ÎÒ¾õµÃÓпÉÄÜÊDzÝËáµÄÎÊÌ⣬Êʵ±Ìá¸ß¼×´¼µÄ±ÈÀýÊÔÊÔ£¿
3Â¥2011-03-11 18:43:28
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 0854£¬¼ÆËã»úÀàÕÐÊÕµ÷¼Á +3 ºúÀ±ÌÀ·ÅÌÇ 2026-03-15 6/300 2026-03-18 12:09 by Éϰ¶Éϰ¶¡­¡­..
[¿¼ÑÐ] 281Çóµ÷¼Á£¨0805£© +4 ÑÌÏ«Ò亣 2026-03-16 11/550 2026-03-18 11:57 by djl2006
[¿¼²©] 26²©Ê¿ÉêÇë +3 1042136743 2026-03-17 3/150 2026-03-17 23:30 by ÇáËɲ»ÉÙËæ
[¿¼ÑÐ] ÓÐûÓеÀÌú/ÍÁľµÄÏëµ÷¼ÁÄÏÁÖ£¬¸ø×Ô¼ºÕÐʦµÜÖС« +3 TqlXswl 2026-03-16 7/350 2026-03-17 15:23 by TqlXswl
[¿¼ÑÐ] 08¹¤¿Æ 320×Ü·Ö Çóµ÷¼Á +4 À滨çóÍí·ç 2026-03-17 4/200 2026-03-17 13:38 by houyaoxu
[¿¼ÑÐ] ²ÄÁÏר˶274Ò»Ö¾Ô¸ÉÂÎ÷ʦ·¶´óѧÇóµ÷¼Á +5 Ñ¦ÔÆÅô 2026-03-13 5/250 2026-03-17 10:15 by Sammy2
[¿¼ÑÐ] 267Ò»Ö¾Ô¸ÄϾ©¹¤Òµ´óѧ0817»¯¹¤Çóµ÷¼Á +6 SUICHILD 2026-03-12 6/300 2026-03-17 09:24 by ÎíÉ¢ºóÏàÓölc
[¿¼ÑÐ] 278Çóµ÷¼Á +3 Yy7400 2026-03-13 3/150 2026-03-17 08:24 by laoshidan
[¿¼ÑÐ] 11408 Ò»Ö¾Ô¸Î÷µç£¬277·ÖÇóµ÷¼Á +3 zhouzhen654 2026-03-16 3/150 2026-03-17 07:03 by laoshidan
[¿¼ÑÐ] 326Çóµ÷¼Á +4 ŵ±´¶û»¯Ñ§½±êéê 2026-03-15 7/350 2026-03-16 17:11 by ŵ±´¶û»¯Ñ§½±êéê
[¿¼ÑÐ] Ò»Ö¾Ô¸211 0703·½Ïò310·ÖÇóµ÷¼Á +3 ŬÁ¦·Ü¶·112 2026-03-15 3/150 2026-03-16 16:44 by houyaoxu
[¿¼ÑÐ] 327Çóµ÷¼Á +6 ʰ¹âÈÎȾ 2026-03-15 11/550 2026-03-15 22:47 by ʰ¹âÈÎȾ
[¿¼ÑÐ] 308 085701 ËÄÁù¼¶ÒѹýÇóµ÷¼Á +7 ÎÂÇÇÇÇÇÇÇÇ 2026-03-12 14/700 2026-03-14 10:49 by JourneyLucky
[¿¼ÑÐ] 304Çóµ÷¼Á +6 Mochaaaa 2026-03-12 7/350 2026-03-13 22:18 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] Çó²ÄÁϵ÷¼Á +5 ¸ô±Ú³ÂÏÈÉú 2026-03-12 5/250 2026-03-13 22:03 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] £Û0860£Ý321·ÖÇóµ÷¼Á£¬abÇø½Ô¿É +4 ±¦¹óÈÈ 2026-03-13 4/200 2026-03-13 22:01 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 315Çóµ÷¼Á +9 СÑòСÑò_ 2026-03-11 10/500 2026-03-13 21:13 by SXNUÀîÀÏʦ
[¿¼ÑÐ] ÍÁľµÚÒ»Ö¾Ô¸276Çóµ÷¼Á£¬¿ÆÑкͼ¼ÄÜÊ®·Ö·á¸»£¬ÇóÐÂÐË·½ÏòµÄµ¼Ê¦ÊÕÁô +3 ÍÁľСÌì²Å 2026-03-12 3/150 2026-03-13 15:01 by JourneyLucky
[¿¼ÑÐ] 0817»¯Ñ§¹¤³ÌÓë¼¼Êõ¿¼ÑÐ312·Öµ÷¼Á +3 T123 tt 2026-03-12 3/150 2026-03-13 10:49 by houyaoxu
[¿¼²©] ¸£ÖÝ´óѧÑî»ÆºÆ¿ÎÌâ×éÕÐÊÕ2026Äêרҵѧλ²©Ê¿Ñо¿Éú£¬2026.03.20½ØÖ¹ +3 Xiangyu_ou 2026-03-12 3/150 2026-03-13 09:36 by duanwu655
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û